| Hans-Günter Meyer-Thompson | Naloxon
USA. FDA Approves Amphastar Pharma's Nasal Spray for Opioid Overdose
USA. FDA Approves Amphastar Pharma's Nasal Spray for Opioid Overdose
Amphastar Pharmaceuticals Inc said on Wednesday the U.S. Food and Drug Administration (FDA) had approved its nasal spray for emergency treatment of known or suspected opioid overdose. (Reuters, USA, 09.03.2023)